Sponsor pipeline

Guangdong Hengrui Pharmaceutical Co., Ltd clinical trial pipeline

Get alerts when Guangdong Hengrui Pharmaceutical Co., Ltd's trials change

31 active trials 19 recruiting 7 Phase 3 10 disease areas 3 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-11

What changed in the last 30 days

2 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 1 with a minor change only.

Show 1 trial with minor changes only
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-09-17 NCT07826364 A Randomized, Double-Blind, Dose-Escalation, Placebo-Controlled Study of SHR-1179… Phase 1 Not Yet Recruiting

Active trials by phase

Phase 1
7
Phase 2
17
Phase 2/3
2
Phase 3
5

Active trials top 25 of 31

NCT IDTitleConditionStatusUpdated
Phase 3
NCT07309055 A Study of SHR-1819 Injection in Adolescents With Severe Atopic Dermatitis Adolescents With Moderate-to-severe Atopic Dermatitis Recruiting 2026-09-08
NCT07688772 A Clinical Study Evaluating the Efficacy and Safety of SHR-1819 Injection in Patients… Seasonal Allergic Rhinitis Recruiting 2026-08-17
NCT07132827 Efficacy and Safety of SHR-1905 Injection in Subjects With Chronic Rhinosinusitis With… Chronic Rhinosinusitis With Nasal Polyps Recruiting 2025-11-17
NCT07098403 A Trial of SHR-1905 in Subjects With Severe Uncontrolled Asthma Asthma Recruiting 2025-09-09
NCT06653322 A Multi-centered,Randomized,Double-blind,Placebo-controlled Study to Evaluate the… Asthma With Eosinophilic Phenotype Active, Not Recruiting 2026-08-10
Phase 2/3
NCT06554509 Clinical Study of the Efficacy and Safety of SHR-1819 Injection in Adult Patients With… Prurigo Nodularis Recruiting 2026-04-29
NCT05979051 A Study to Evaluate the Efficacy and Safety of SHR-1703 in Subjects With Eosinophilic… Eosinophilic Granulomatosis With Polyangiitis Recruiting 2025-12-04
Phase 2
NCT07299422 A Study of SHR-2173 in Participants With Systemic Lupus Erythematosus Systemic Lupus Erythematosus Recruiting 2026-09-29
NCT07719530 Phase II Clinical Trial of SHR-1139 Injection in Patients With Psoriasis Psoriasis Recruiting 2026-08-20
NCT07640451 A Clinical Trial to Evaluate the Efficacy and Safety of HRS-9821 Inhalation Suspension in… COPD Recruiting 2026-08-18
NCT07354932 A Study of SHR-2173 in Participants With Primary IgA Nephropathy Primary IgA Nephropathy Recruiting 2026-05-13
NCT07211542 A Study to Investigate the Efficacy and Safety of SHR-1905 in Patients With… Moderate-to-severe Atopic Dermatitis Recruiting 2026-04-08
NCT07289763 Phase II Randomized, Open-label, Multicenter Clinical Study Evaluating the Safety… Primary Membranous Nephropathy Recruiting 2026-01-26
NCT07192939 Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Trial to Evaluate the… IPF and PPF Recruiting 2025-12-24
NCT06441812 A Study to Evaluate the Long-term Safety, Pharmacodynamics and Efficacy of SHR-1703 in… Eosinophilic Asthma Patients Recruiting 2025-12-18
NCT07229742 A Phase II Clinical Study on the Efficacy and Safety of SHR-2173 Injection in the… Active Lupus Nephritis Recruiting 2025-12-01
NCT07758075 A Phase II Clinical Study to Evaluate the Efficacy and Safety of SHR-1139 Injection in… Plaque Psoriasis Not Yet Recruiting 2026-08-11
NCT07232576 A Phase 2 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of SHR-1139 in… Adult Patients With Moderately to Severely Active Ulcerative Colitis Active, Not Recruiting 2026-06-04
NCT07321951 A Study of SHR-1819 in Patients With Moderate-to-severe Atopic Dermatitis Moderate-to-severe Atopic Dermatitis Active, Not Recruiting 2026-06-04
NCT07622342 A Phase II Study of SHR-2173 Injection in Patients With Myasthenia Gravis Generalized Myasthenia Gravis Not Yet Recruiting 2026-06-03
NCT07233655 A Phase II Trial of SHR-3045 Injection in Patients With Rheumatoid Arthritis Moderate to Severe Active Rheumatoid Arthritis Active, Not Recruiting 2026-05-01
NCT07444684 A Study to Evaluate SHR-1139 Injection in Patients With Pyoderma Gangrenosum Pyoderma Gangrenosum Not Yet Recruiting 2026-03-03
NCT06875934 A Trial Comparing SHR-1139 Injection With Placebo in Patients With Moderate-to-severe… Moderate to Severe Plaque Psoriasis Active, Not Recruiting 2025-07-14
NCT06940700 Clinical Study on the Efficacy and Safety of SHR-4597 Inhalant in Adult Patients With… Asthma Not Yet Recruiting 2025-04-23
Phase 1
NCT07758101 A Study to Evaluate the Safety of SHR-7590 in Chinese Healthy Participants and in… Moderate-to-severe Inflammatory Bowel Disease Recruiting 2026-09-25

Disease areas by active trials

Get alerts when Guangdong Hengrui Pharmaceutical Co., Ltd's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free